**Abstract**

Bipolar disorder is a common neuropsychiatric disorder characterized by manic and depressive episodes with life time prevalence of around 1%. Although the pathogenesis of bipolar disorder is not well understood, genetic factors are known to be important in bipolar disorder. Recently, a *de novo* frameshift mutation in *EHD1* (*Eps15 homology domain 1*), predicted to generate a truncated EHD1 protein, was reported by a trio-based exome sequencing study of bipolar disorder. EHD1 possesses the EH domain including the EF-hand calcium binding domain, and plays important roles in the recycling of receptors from endosomes to the plasma membrane and the cell differentiation. In the present study, we analyzed the function of mutant EHD1 protein which is predicted to be generated by a mutation identified in a bipolar disorder patient. We determined the recycling endocytosis activity in EHD1 mutant-expressing PC12 cells by using Alexa488-conjugated transferrin and fluorescence activated cell sorting. Our preliminarily experiment showed that the EHD1 mutant might inhibit the activity of recycling endocytosis. We also found that the EHD1 mutant-expressing PC12 cells significantly inhibited the efficiency of nerve growth factor-induced differentiation. These findings suggest that the mutation of *EHD1* found in a patient with bipolar disorder impairs the function of EHD1 in differentiation of PC12 cells. The present results could be shed light on the pathophysiological mechanisms of bipolar disorder at the cellular level.
